NCT02295241

Brief Summary

The primary aim of this study is to compare traditional muscle function tests with computerized versions using body-worn motion sensors and video motion analysis of the same tests. The investigators selected the Timed Up and Go (TUG) test as the investigators primary variable for this aim with several other function tests (e.g., repeated chair rise, 6-meter walk, 2-minute walk, Romberg stance, semi-tandem / tandem stance) as secondary variables. The investigators primary hypothesis is that the computerized versions of the TUG test are highly correlated (\>0.9) with the traditional method, but with comparable or better reproducibility. Secondary analyses will correlate other function tests with their computerized version, again with the hypothesis that they are highly correlated and that computerized versions are of similar or better reproducibility. This analysis will also compare traditional assessments of balance with a computerized balance method, computerized dynamic posturography.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
112

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2015

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 3, 2014

Completed
2 months until next milestone

First Posted

Study publicly available on registry

November 20, 2014

Completed
2 months until next milestone

Study Start

First participant enrolled

February 1, 2015

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2015

Completed
Last Updated

March 28, 2016

Status Verified

March 1, 2016

Enrollment Period

8 months

First QC Date

October 3, 2014

Last Update Submit

March 25, 2016

Conditions

Keywords

Sarcopenia, muscles, aging

Outcome Measures

Primary Outcomes (1)

  • The comparison of results of traditional physical function tests with the results of computerized versions (body worn sensors and Kinect system) of the same tests.

    Short-term reproducibility of traditional vs. computerized functional tests will also be compared.

    All physical function tests will be performed at the first visit and visit 2 up to 4 days later

Secondary Outcomes (3)

  • Explore the capabilities of the Microsoft Kinect system to record and analyze muscle function tests and correlate the Microsoft Kinect system to a gold standard motion analysis system.

    All physical function tests will be performed at the first visit and visit 2 up to 4 days later.

  • Validate the use of BIS (Bioelectrical Impedance Spectroscopy) to adjust DXA (Dual Energy X-ray Absorptiometry) -measured body composition by providing muscle mass measurement

    BIS is performed at visit 1 and visit 2 up to 4 days later. DXA is performed at visit 2.

  • Correlate various ratios of lean or muscle mass / DXA measured fat mass with functional tests.

    All physical function tests will be performed at the screen and follow up visits.

Interventions

This is an observational trial, no interventions are being used.

Eligibility Criteria

Age70 Years+
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

This study will evaluate community dwelling women and men ≥ 70 years recruited from the Madison, Wisconsin area.

You may qualify if:

  • Ambulatory, community dwelling men and women age ≥ 70 years
  • Able and willing to sign informed consent
  • Able to stand without assistance

You may not qualify if:

  • History of myocardial infarction within the prior six months or ongoing angina
  • History of injury or surgery within the prior six months which limits the ability to ambulate
  • History of malignancy with metastasis to the musculoskeletal system
  • Neuromuscular disease or severe end organ disease impairing balance or muscle function to the degree that completion of all study tests is unlikely.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Wisconsin-Madison Osteoporosis Clinical Research Program

Madison, Wisconsin, 53705, United States

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

Blood will be drawn to obtain a serum chemistry panel to document health status of the study participants. For subjects who agree to optional banking, serum aliquots will be obtained and banked for future study of markers relevant to musculoskeletal health.

MeSH Terms

Conditions

Sarcopenia

Condition Hierarchy (Ancestors)

Muscular AtrophyNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesAtrophyPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsSigns and Symptoms

Study Officials

  • Neil Binkley, M.D.

    University of Wisconsin, Madison

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 3, 2014

First Posted

November 20, 2014

Study Start

February 1, 2015

Primary Completion

October 1, 2015

Study Completion

October 1, 2015

Last Updated

March 28, 2016

Record last verified: 2016-03

Locations